Product ID |
CAS Number |
Product Name |
Quantity |
AS-0048 |
67853-37-6 |
2-Bromo-3-nitroanisole |
|
AS-0459 |
50606-58-1 |
1-Benzyl-3-piperidone hydrochloride |
|
AS-0680 |
459-31-4 |
3-(4-FLUOROPHENYL)PROPIONIC ACID |
|
AS-0695 |
22246-18-0 |
3,4-Dihydro-7-hydroxy-2(1H)-quinolinone |
|
AS-0876 |
611-36-9 |
4-Hydroxyquinoline |
|
AS-0934 |
12/9/5550 |
Guanosine 5'-monophosphate disodium salt |
|
AS-0967 |
75680-92-1 |
6-Chloro-pyridazine-3-carboxylic acid ethyl ester |
|
AS-1016 |
657-27-2 |
L-Lysine hydrochloride |
|
AS-1224 |
51-41-2 |
Norepinephrine |
|
AS-1317 |
591-54-8 |
4-Aminopyrimidine |
|
AS-1666 |
652-34-6 |
2,3,5,6-Tetrafluoro-4-hydroxy-benzoic acid |
|
AS-1805 |
59782-85-3 |
2,5-Dichloronicotinic acid |
|
AS-1822 |
1897-52-5 |
2,6-Difluorobenzonitrile |
|
AS-2165 |
120-93-4 |
Ethyleneurea |
|
AS-2743 |
130047-19-7 |
4-FLUORO-2-(TRIFLUOROMETHYL)PHENOL |
|
AS-3392 |
585-79-5 |
3-Bromonitrobenzene |
|
AS-3509 |
6224-63-1 |
TRI-M-TOLYLPHOSPHINE |
|
AS-3748 |
141-86-6 |
2,6-Diaminopyridine |
|
AS-4569 |
27060-75-9 |
2-Bromo-5-methoxytoluene |
|
AS-5098 |
25596-24-1 |
TRIMETHYLSULFOXONIUM BROMIDE |
|
AS-5191 |
2215-89-6 |
4,4'-Oxybisbenzoic acid |
|
AS-6038 |
6092-54-2 |
HEXYL CHLOROFORMATE |
|
AS-6046 |
588-96-5 |
4-Bromophenetole |
|
AS-6076 |
4499-86-9 |
Tetrapropylammonium hydroxide |
|
AS-7054 |
127199-27-3 |
3-Quinolinecarboxylic acid, 8-chloro-6,7-difluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo- |
|
AS-7585 |
12354-84-6 |
(Pentamethylcyclopentadienyl)iridium(III) chloride dimer |
|
AS-7587 |
6136-93-2 |
DIETHOXYACETONITRILE |
|
AS-7822 |
6149-41-3 |
METHYL 3-HYDROXYPROPANOATE |
|
AS-7933 |
104944-18-5 |
H-D-Val-OtBu.HCl |
|
AS-8801 |
677728-92-6 |
2-Fluoropyridine-5-carboxaldehyde |
|
AS-8898 |
933752-32-0 |
1,2,3,4-TETRAHYDROISOQUINOLINE-6-CARBOXYLIC ACID |
|
JR6-L6378 |
176721-03-2 |
1H-Imidazole-4-methanol, a-(2,3-dimethylphenyl)-a-methyl-1-(triphenylmethyl)- |
|
JR8-N0224 |
539-15-1 |
Hordenine |
|
JR8-N0249 |
52659-56-0 |
Kirenol |
|
JR8-N0900 |
59092-91-0 |
Albaspidin AP |
|
|
|
|
|
|
|
|
|
|
|
|
|